TY  - GEN
AU  - Serrano,César
AU  - Mariño-Enríquez,Adrián
AU  - Tao,Derrick L
AU  - Ketzer,Julia
AU  - Eilers,Grant
AU  - Zhu,Meijun
AU  - Yu,Channing
AU  - Mannan,Aristotle M
AU  - Rubin,Brian P
AU  - Demetri,George D
AU  - Raut,Chandrajit P
AU  - Presnell,Ajia
AU  - McKinley,Arin
AU  - Heinrich,Michael C
AU  - Czaplinski,Jeffrey T
AU  - Sicinska,Ewa
AU  - Bauer,Sebastian
AU  - George,Suzanne
AU  - Fletcher,Jonathan A
TI  - Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
SN  - 1532-1827
PY  - 2019///1216
KW  - Animals
KW  - CHO Cells
KW  - Clinical Trials, Phase II as Topic
KW  - Cricetulus
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gastrointestinal Neoplasms
KW  - drug therapy
KW  - Gastrointestinal Stromal Tumors
KW  - Humans
KW  - Imatinib Mesylate
KW  - pharmacology
KW  - Mice
KW  - Mice, Nude
KW  - Mutation
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-kit
KW  - antagonists & inhibitors
KW  - Pyridines
KW  - Sunitinib
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1038/s41416-019-0389-6
ER  -